These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 22193343

  • 1. Peripheral blood lymphocyte dynamics and viral kinetics in patients with chronic active hepatitis B virus infection treated by tenofovir.
    Arasli M, Ustundag Y, Delikanli B, Harmandar F, Buyukuysal C.
    Hepatogastroenterology; 2012 May; 59(115):851-7. PubMed ID: 22193343
    [Abstract] [Full Text] [Related]

  • 2. Impact of viral replication inhibition by entecavir on peripheral T lymphocyte subpopulations in chronic hepatitis B patients.
    You J, Sriplung H, Geater A, Chongsuvivatwong V, Zhuang L, Li YL, Lei H, Liu J, Chen HY, Tang BZ, Huang JH.
    BMC Infect Dis; 2008 Sep 22; 8():123. PubMed ID: 18803883
    [Abstract] [Full Text] [Related]

  • 3. Impact of early viral kinetics on T-cell reactivity during antiviral therapy in chronic hepatitis B.
    Lau GK, Cooksley H, Ribeiro RM, Powers KA, Shudo E, Bowden S, Hui CK, Anderson J, Sorbel J, Mondou E, Rousseau F, Lewin S, Perelson AS, Locornini S, Naoumov NV.
    Antivir Ther; 2007 Sep 22; 12(5):705-18. PubMed ID: 17713154
    [Abstract] [Full Text] [Related]

  • 4. Regulatory T-cell responses in chronic hepatitis B patients treated with nucleos(t)ide analogs compared with healthy subjects and untreated infected individuals.
    Chen LY, Zhu LY, Yang BS, Bi MR, Yan BZ, Wang W, Ma YJ.
    Hepatogastroenterology; 2012 Sep 22; 59(120):2582-6. PubMed ID: 22626879
    [Abstract] [Full Text] [Related]

  • 5. [Studies about the level of CD4+ CD25+ regulatory T cells and relation between expression of Foxp3 and CD127 in peripheral blood of chronic HBV infection].
    Deng M, Li MH, Liu SA, Liu F, Sang Y, Song SJ, Zang SF, Guan XP, Yao X, Wu XP, Cheng J, Xu DZ.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Feb 22; 24(1):21-3. PubMed ID: 20848841
    [Abstract] [Full Text] [Related]

  • 6. Viral dynamics during tenofovir therapy in patients infected with lamivudine-resistant hepatitis B virus mutants.
    van der Eijk AA, Hansen BE, Niesters HG, Janssen HL, van de Ende M, Schalm SW, de Man RA.
    J Viral Hepat; 2005 Jul 22; 12(4):364-72. PubMed ID: 15985006
    [Abstract] [Full Text] [Related]

  • 7. Dissection of a circulating and intrahepatic CD4(+)Foxp3(+) T-cell subpopulation in chronic hepatitis B virus (HBV) infection: a highly informative strategy for distinguishing chronic HBV infection states.
    Zhang M, Zhou J, Zhao T, Huang G, Tan Y, Tan S, Fu X, Niu W, Meng G, Chen X, Shang X, Liu D, Ni B, Wang L, Wu Y.
    J Infect Dis; 2012 Apr 01; 205(7):1111-20. PubMed ID: 22357657
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of the efficacy of entecavir and tenofovir in chronic hepatitis B.
    Güzelbulut F, Ovünç AO, Oetinkaya ZA, Senates E, Gökden Y, Saltürk AG, Sezikli M, Ozkara S, Cetinkaya F.
    Hepatogastroenterology; 2012 Apr 01; 59(114):477-80. PubMed ID: 21940383
    [Abstract] [Full Text] [Related]

  • 10. Association of CD4+CD25+Foxp3+ regulatory T cells with chronic activity and viral clearance in patients with hepatitis B.
    Yang G, Liu A, Xie Q, Guo TB, Wan B, Zhou B, Zhang JZ.
    Int Immunol; 2007 Feb 01; 19(2):133-40. PubMed ID: 17182968
    [Abstract] [Full Text] [Related]

  • 11. Monitoring of CD95 and CD38 expression in peripheral blood T lymphocytes during active human cytomegalovirus infection after orthotopic liver transplantation.
    Wang Y, Liu Y, Han R, Li Q, Yao Z, Niu W, Yuan Y, Tang Z, Zhu Z, Shen Z.
    J Gastroenterol Hepatol; 2010 Jan 01; 25(1):138-42. PubMed ID: 19817952
    [Abstract] [Full Text] [Related]

  • 12. Telbivudine decreases proportion of peripheral blood CD4+CD25+CD127low T cells in parallel with inhibiting hepatitis B virus DNA.
    Yan Z, Zhou J, Zhang M, Fu X, Wu Y, Wang Y.
    Mol Med Rep; 2014 May 01; 9(5):2024-30. PubMed ID: 24626572
    [Abstract] [Full Text] [Related]

  • 13. Intrahepatic regulatory T cells are phenotypically distinct from their peripheral counterparts in chronic HBV patients.
    Stoop JN, Claassen MA, Woltman AM, Binda RS, Kuipers EJ, Janssen HL, van der Molen RG, Boonstra A.
    Clin Immunol; 2008 Dec 01; 129(3):419-27. PubMed ID: 18823821
    [Abstract] [Full Text] [Related]

  • 14. Viral infection parameters not nucleoside analogue itself correlates with host immunity in nucleoside analogue therapy for chronic hepatitis B.
    Li CZ, Hu JJ, Xue JY, Yin W, Liu YY, Fan WH, Xu H, Liang XS.
    World J Gastroenterol; 2014 Jul 28; 20(28):9486-96. PubMed ID: 25071343
    [Abstract] [Full Text] [Related]

  • 15. Tenofovir therapy in hepatitis B virus-positive solid-organ transplant recipients.
    Daudé M, Rostaing L, Sauné K, Lavayssière L, Basse G, Esposito L, Guitard J, Izopet J, Alric L, Kamar N.
    Transplantation; 2011 Apr 27; 91(8):916-20. PubMed ID: 21325995
    [Abstract] [Full Text] [Related]

  • 16. Relations of regulatory T cells with hepatitis markers in chronic hepatitis B virus infection.
    El-Badawy O, Sayed D, Badary MS, Abd-Alrahman ME, El-Feky MA, Thabit AG.
    Hum Immunol; 2012 Apr 27; 73(4):335-41. PubMed ID: 22342871
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.